Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Mixed results for BMS’ Opdivo, Yervoy combo in kidney cancer

pharmatimesAugust 17, 2017

Tag: BMS , Opdivo , Yervoy

PharmaSources Customer Service